Cologuard® revenue increased 168 percent to $266 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Exact Sciences (EXAS) Tops Q4 EPS by 6c
February 22, 2018 4:06 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $87.4 million versus the consensus estimate of $85.74 million.
GUIDANCE:
Exact Sciences sees FY2018 revenue of $420-430 million, versus the consensus of $422.13... More



